Menu Search
Equities

Varex Imaging Corp

VREX:NSQ

Varex Imaging Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)16.51
  • Today's Change1.09 / 7.07%
  • Shares traded27.00
  • 1 Year change-15.12%
  • Beta0.5830
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Varex Imaging Corp's revenues fell -9.22% from 893.40m to 811.00m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a gain of 48.20m to a loss of 47.70m.
Gross margin31.68%
Net profit margin-5.82%
Operating margin3.96%
Return on assets-3.83%
Return on equity-8.65%
Return on investment-4.54%
More ▼

Cash flow in USDView more

In 2024, Varex Imaging Corp increased its cash reserves by 10.65%, or 16.40m. The company earned 47.30m from its operations for a Cash Flow Margin of 5.83%. In addition the company used 27.50m on investing activities and also paid 3.30m in financing cash flows.
Cash flow per share-0.3924
Price/Cash flow per share--
Book value per share13.02
Tangible book value per share5.55
More ▼

Balance sheet in USDView more

Varex Imaging Corp has a Debt to Total Capital ratio of 45.02%, a lower figure than the previous year's 77.74%.
Current ratio3.32
Quick ratio1.97
Total debt/total equity0.8404
Total debt/total capital0.4502
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.